HeartSciences Inc. reported receiving $2.8 million from an ongoing Regulation A Offering, with a maximum goal of $15 million, as of July 16, 2025. They have issued 797,452 Units, resulting in 486,815 shares of Series D Preferred Stock converted to Common Stock, totaling 1,797,914 shares outstanding.